Original Article Online Published: 31 Dec 2023 | ||||||||||||
IJMDC. 2024; 8(3): 961-967 Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia Abdullah Mofareh Alshehri, Anas Saeed Almalki, Majed Mohammed Althomali, Nawaf Abed Altowarqi, Hassan Saleh Almalki, Ayman Abdelbaky Atalla.
|
How to Cite this Article |
Pubmed Style Alshehri AM, Almalki AS, Althomali MM, Altowarqi NA, Almalki HS, Atalla AA. Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. IJMDC. 2024; 8(3): 961-967. doi:10.24911/IJMDC.51-1698694582 Web Style Alshehri AM, Almalki AS, Althomali MM, Altowarqi NA, Almalki HS, Atalla AA. Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. https://www.ijmdc.com/?mno=174985 [Access: February 07, 2025]. doi:10.24911/IJMDC.51-1698694582 AMA (American Medical Association) Style Alshehri AM, Almalki AS, Althomali MM, Altowarqi NA, Almalki HS, Atalla AA. Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. IJMDC. 2024; 8(3): 961-967. doi:10.24911/IJMDC.51-1698694582 Vancouver/ICMJE Style Alshehri AM, Almalki AS, Althomali MM, Altowarqi NA, Almalki HS, Atalla AA. Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. IJMDC. (2024), [cited February 07, 2025]; 8(3): 961-967. doi:10.24911/IJMDC.51-1698694582 Harvard Style Alshehri, A. M., Almalki, . A. S., Althomali, . M. M., Altowarqi, . N. A., Almalki, . H. S. & Atalla, . A. A. (2024) Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. IJMDC, 8 (3), 961-967. doi:10.24911/IJMDC.51-1698694582 Turabian Style Alshehri, Abdullah Mofareh, Anas Saeed Almalki, Majed Mohammed Althomali, Nawaf Abed Altowarqi, Hassan Saleh Almalki, and Ayman Abdelbaky Atalla. 2024. Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. International Journal of Medicine in Developing Countries, 8 (3), 961-967. doi:10.24911/IJMDC.51-1698694582 Chicago Style Alshehri, Abdullah Mofareh, Anas Saeed Almalki, Majed Mohammed Althomali, Nawaf Abed Altowarqi, Hassan Saleh Almalki, and Ayman Abdelbaky Atalla. "Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia." International Journal of Medicine in Developing Countries 8 (2024), 961-967. doi:10.24911/IJMDC.51-1698694582 MLA (The Modern Language Association) Style Alshehri, Abdullah Mofareh, Anas Saeed Almalki, Majed Mohammed Althomali, Nawaf Abed Altowarqi, Hassan Saleh Almalki, and Ayman Abdelbaky Atalla. "Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia." International Journal of Medicine in Developing Countries 8.3 (2024), 961-967. Print. doi:10.24911/IJMDC.51-1698694582 APA (American Psychological Association) Style Alshehri, A. M., Almalki, . A. S., Althomali, . M. M., Altowarqi, . N. A., Almalki, . H. S. & Atalla, . A. A. (2024) Assessment of public awareness about Semaglutide (Ozempic) use, safety, and adverse drug reaction in Saudi Arabia. International Journal of Medicine in Developing Countries, 8 (3), 961-967. doi:10.24911/IJMDC.51-1698694582 |